Literature DB >> 15223630

Interactions between tissue fibroblasts in lymph nodes and Hodgkin/Reed-Sternberg cells.

Donatella Aldinucci1, Debora Lorenzon, Karin Olivo, Barbara Rapanà, Valter Gattei.   

Abstract

Classic Hodgkin's Disease (cHD) is a lymphoid neoplasia characterized by a few malignant Hodgkin and Reed-Sternberg (H-RS) cells embedded in an abundant background of non-tumor cells. In this context, fibrosis is a common morphologic feature of HD lesions, being found more frequently in cHD subtypes. The clinical and histopathologic features of cHD are thought to be largely due to the effects of a wide variety of cytokines and chemokines primarily produced by H-RS cells, as well as by the surrounding reactive component. In the present review, first we propose three mechanisms putatively explaining fibroblast activation and fibrosis in HD: (1) unbalanced production of the pro-fibrogenic Th2 over Th1 cytokines; (2) production of TGF-beta, b-FGF and IL-13 by H-RS cells; (3) activation of fibroblasts by CD40L-expressing cells of the HD microenvironment. Second, we suggest some molecular pathways involving cytokines produced by HD-derived fibroblasts (SCF, IL-7, IL-6) supposedly responsible for H-RS proliferation and rescue from apoptosis. Finally, we describe the role of specific molecules produced by H-RS cells in the regulation of HD-derived fibroblast production of chemokines, in turn involved in T-lymphocytes and recruitment of eosinophils. Copyright 2004 Taylor and Francis Ltd

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223630     DOI: 10.1080/10428190410001683633

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  14 in total

Review 1.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

2.  Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma.

Authors:  Robert J Biggar; Julia S Johansen; Karin Ekström Smedby; Klaus Rostgaard; Ellen T Chang; Hans-Olov Adami; Bengt Glimelius; Daniel Molin; Stephen Hamilton-Dutoit; Mads Melbye; Henrik Hjalgrim
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

Review 3.  Cytokines in the microenvironment of Waldenström's macroglobulinemia.

Authors:  Sherine F Elsawa; Stephen M Ansell
Journal:  Clin Lymphoma Myeloma       Date:  2009-03

4.  Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma.

Authors:  Preethi Reddy Marri; Lucy S Hodge; Matthew J Maurer; Steven C Ziesmer; Susan L Slager; Thomas M Habermann; Brian K Link; James R Cerhan; Anne J Novak; Stephen M Ansell
Journal:  Clin Cancer Res       Date:  2013-10-18       Impact factor: 12.531

5.  EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines.

Authors:  Shu-Chun Tsai; Sue-Jane Lin; Po-Wen Chen; Wen-Yi Luo; Te-Huei Yeh; Hsei-Wei Wang; Chi-Ju Chen; Ching-Hwa Tsai
Journal:  Blood       Date:  2009-05-05       Impact factor: 22.113

6.  Interleukin (IL)-7 Signaling in the Tumor Microenvironment.

Authors:  Iwona Bednarz-Misa; Mariusz A Bromke; Małgorzata Krzystek-Korpacka
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications.

Authors:  Luis de la Cruz-Merino; Marylène Lejeune; Esteban Nogales Fernández; Fernando Henao Carrasco; Ana Grueso López; Ana Illescas Vacas; Mariano Provencio Pulla; Cristina Callau; Tomás Álvaro
Journal:  Clin Dev Immunol       Date:  2012-08-15

8.  Dermal fibroblasts promote cancer cell proliferation and exhibit fibronectin overexpression in early mycosis fungoides.

Authors:  Burcu Beksaç; Laura Gleason; Sarah Baik; John M Ringe; Pierluigi Porcu; Neda Nikbakht
Journal:  J Dermatol Sci       Date:  2022-03-14       Impact factor: 5.408

9.  Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies.

Authors:  Theodoros Karantanos; Ioannis Politikos; Vassiliki A Boussiotis
Journal:  Blood Lymphat Cancer       Date:  2017-05-09

10.  Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype.

Authors:  Bastian Dörsam; Teresa Bösl; Katrin S Reiners; Sabine Barnert; Rolf Schubert; Olga Shatnyeva; Paola Zigrino; Andreas Engert; Hinrich P Hansen; Elke Pogge von Strandmann
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.